Published in Arch Dermatol on March 01, 2007
The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. J Am Acad Dermatol (2012) 0.96
Toll-like receptors and cutaneous melanoma. Oncol Lett (2016) 0.75
Regression of nevi in a melanoma patient treated with interferon. Dermatol Pract Concept (2012) 0.75
Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions. Arch Dermatol (2007) 4.36
Osteopontin expression correlates with melanoma invasion. J Invest Dermatol (2005) 3.13
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest (2003) 2.37
Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J Clin Oncol (2005) 2.01
The histologic spectrum of cutaneous sarcoidosis: a study of twenty-eight cases. J Cutan Pathol (2004) 1.75
Calciphylaxis in the current era: emerging 'ironic' features? Nephrol Dial Transplant (2010) 1.58
Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res (2006) 1.57
Actinic granuloma is a unique and distinct entity: a comparative study with granuloma annulare. Am J Dermatopathol (2002) 1.54
Topical resiquimod promotes priming of CTL to parenteral antigens. Vaccine (2009) 1.50
Usefulness of Interferon-γ release assays in the diagnosis of erythema induratum. Arch Dermatol (2011) 1.40
Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis (2008) 1.40
In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol (2002) 1.30
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26
PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene (2005) 1.25
New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther (2007) 1.24
A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Can J Gastroenterol (2009) 1.23
Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes (2002) 1.20
Optimization of epicutaneous immunization for the induction of CTL. Vaccine (2003) 1.19
Decidual NK cells alter in vitro first trimester extravillous cytotrophoblast migration: a role for IFN-gamma. J Immunol (2006) 1.17
Better influenza vaccines for older people: what will it take? J Infect Dis (2008) 1.17
Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol (2007) 1.11
TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J Immunol (2010) 1.09
Bim expression is reduced in human cutaneous melanomas. J Invest Dermatol (2007) 1.09
Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion. Am J Pathol (2010) 1.08
Cutaneous GVHD is associated with the expansion of tissue-localized Th1 and not Th17 cells. Blood (2010) 1.07
Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol (2004) 1.05
XAF1 expression is significantly reduced in human melanoma. J Invest Dermatol (2004) 1.05
Molecular markers of early-stage mycosis fungoides. J Invest Dermatol (2012) 1.04
Loss of SNF5 expression correlates with poor patient survival in melanoma. Clin Cancer Res (2009) 1.02
Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol (2002) 1.01
Prognostic significance of nuclear ING3 expression in human cutaneous melanoma. Clin Cancer Res (2007) 1.01
Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+CD25+ T regulatory cells and is dependent on host-derived IL-10. J Immunol (2006) 1.00
Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology (Oxford) (2011) 1.00
Prognostic significance of cytoplasmic p27 expression in human melanoma. Cancer Epidemiol Biomarkers Prev (2011) 0.98
MMP2 expression is a prognostic marker for primary melanoma patients. Cell Oncol (Dordr) (2012) 0.97
Prognostic significance of RUNX3 expression in human melanoma. Cancer (2010) 0.96
Clinicopathologic features and behavior of cutaneous eyelid melanoma. Ophthalmology (2002) 0.95
Role of Tip60 in human melanoma cell migration, metastasis, and patient survival. J Invest Dermatol (2012) 0.95
Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am J Physiol Gastrointest Liver Physiol (2012) 0.95
Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol (2013) 0.94
Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival. PLoS One (2011) 0.94
Site-specific protective effect of broad-spectrum sunscreen on nevus development among white schoolchildren in a randomized trial. J Am Acad Dermatol (2005) 0.93
Expression of the RNase III enzyme DROSHA is reduced during progression of human cutaneous melanoma. Mod Pathol (2013) 0.93
Topical CpG enhances the response of murine malignant melanoma to dacarbazine. J Invest Dermatol (2008) 0.93
Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis. Oncotarget (2014) 0.92
Reversible retiform purpura: a sign of cocaine use. CMAJ (2011) 0.92
The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas. Oncol Rep (2010) 0.92
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles. Int Immunol (2009) 0.90
Prognostic significance of nuclear factor-kappaB p105/p50 in human melanoma and its role in cell migration. Cancer Res (2006) 0.90
Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL. J Invest Dermatol (2004) 0.89
A combination of p300 and Braf expression in the diagnosis and prognosis of melanoma. BMC Cancer (2014) 0.88
Myeloid leukemia-1 expression in benign and malignant melanocytic lesions. Oncol Rep (2008) 0.88
Benign lichenoid keratoses with histologic features of mycosis fungoides: clinicopathologic description of a clinically significant histologic pattern. J Cutan Pathol (2002) 0.88
Prognostic significance of Fbw7 in human melanoma and its role in cell migration. J Invest Dermatol (2013) 0.88
Prognostic significance of KAI1/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4. Carcinogenesis (2013) 0.88
Elevated expression of Rad18 regulates melanoma cell proliferation. Pigment Cell Melanoma Res (2012) 0.87
Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma. Int J Oncol (2003) 0.86
Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. J Am Acad Dermatol (2002) 0.86
Long-standing spiny papules on the lower extremities. Flegel disease, or hyperkeratosis lenticularis perstans (HLP). Arch Dermatol (2008) 0.86
Psychiatric disorders in patients with immune-mediated inflammatory diseases: prevalence, association with disease activity, and overall patient well-being. J Rheumatol Suppl (2011) 0.85
Cutaneous manifestations of eating disorders. J Cutan Med Surg (2002) 0.85
Cul1 expression is increased in early stages of human melanoma. Pigment Cell Melanoma Res (2010) 0.85
Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation (2009) 0.85
The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol (2003) 0.85
Post-surgical treatment of melanoma in situ of the vulva with imiquimod. J Obstet Gynaecol Can (2010) 0.84
Tinea faciei mimicking cutaneous lupus erythematosus: a histopathologic case report. J Am Acad Dermatol (2003) 0.83
Fatal squamous cell carcinoma arising from transplant-associated porokeratosis. J Am Acad Dermatol (2003) 0.83
Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea. Exp Dermatol (2012) 0.83
IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors. Mol Hum Reprod (2008) 0.83
Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev (2009) 0.82
Topical TLR9 agonists induce more efficient cross-presentation of injected protein antigen than parenteral TLR9 agonists do. Eur J Immunol (2007) 0.82
Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair. Int J Oncol (2004) 0.82
C-terminal tensin-like protein is a novel prognostic marker for primary melanoma patients. PLoS One (2013) 0.81
Endothelin-3 is produced by metastatic melanoma cells and promotes melanoma cell survival. J Cutan Med Surg (2008) 0.81
Bullous pemphigoid associated with acquired hemophilia a: a rare association of autoimmune disease. J Cutan Med Surg (2014) 0.81
Paradoxical hypertrichosis after laser epilation. J Am Acad Dermatol (2005) 0.81
Progression of spontaneous autoimmune diabetes is associated with a switch in the killing mechanism used by autoreactive CTL. Int Immunol (2004) 0.80
Neurosyphilitic gumma in a homosexual man with HIV infection confirmed by polymerase chain reaction. Int J STD AIDS (2008) 0.80
Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel. Acta Derm Venereol (2007) 0.80
Dermatology practice in primary health care services: where do we stand in the Middle East? Int J Dermatol (2002) 0.79
Trichodysplasia spinulosa: rare presentation of polyomavirus infection in immunocompromised patients. J Cutan Med Surg (2014) 0.79
Early detection of skin cancer by family physicians: a pilot project. J Cutan Med Surg (2004) 0.79
JWA inhibits melanoma angiogenesis by suppressing ILK signaling and is an independent prognostic biomarker for melanoma. Carcinogenesis (2013) 0.79
Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial. Dermatology (2010) 0.79
Decreased expression of nuclear p300 is associated with disease progression and worse prognosis of melanoma patients. PLoS One (2013) 0.79
Mucoepidermoid carcinoma of the parotid presenting as periauricular cystic nodules: a series of four cases. J Cutan Pathol (2012) 0.78
Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens. Biol Blood Marrow Transplant (2011) 0.78
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes. Vaccine (2004) 0.78
Skin immune responses to peptide and protein antigen are TLR4 independent. Cell Immunol (2003) 0.78
The significance of Melan-A-positive pagetoid melanocytosis in dysplastic nevi. Am J Dermatopathol (2014) 0.77
A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis? Pediatr Dermatol (2004) 0.77
Atrophie blanche: is it associated with venous disease or livedoid vasculopathy? Adv Skin Wound Care (2014) 0.77
Trichoblastic sarcoma with osteosarcomatous differentiation: evolution of one lesion with 3 histologic appearances over a 3-year period. Am J Dermatopathol (2012) 0.77
Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes. Clin Vaccine Immunol (2014) 0.77
Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia. J Clin Immunol (2012) 0.77